Philips’ (PHG) shares have gained 13.5% in the year-to-date period, outperforming the Zacks Medical sector’s growth of 5%. The company is continuously gaining from a strong Diagnosis & Treatment segment. It is making concerted efforts to bolster this segment further on the back of strengthening Precision Diagnosis and Image-Guided Therapy businesses. These efforts are evident from the latest launch of Philips Image Guided Therapy Mobile C-arm System 9000, Zenition 90 Motorized, enhancing clinicians' product ...